Triglyceride-glucose index as predictor of gestational diabetes mellitus in early pregnancy: a prospective cohort study

• by Ge Huang, Meng Su, Cheng Li, Hongzhuan Tan, Jing Deng, Mengshi Chen

• June 29, 2026

Solution for the hot spots in adaptive radiotherapy planning for cervical cancer: a case report and review of literature

• by Peng Jiang, Xiang Wang, Shubao Cui, Chengyu Ren, Zilu Wang, Yongchun Zhang, Xiaoqian Wu

• June 26, 2026

Roswell Park Introduces Gyn-Onc Connect Line for Consultation

To better service community practitioners, Roswell Park Comprehensive Cancer Center is proud to introduce Gyn-Onc Connect, a dedicated phone number to access Roswell Park’s gynecologic oncology team.

• by

• June 29, 2026

• 1 min

Roswell Park Launches Exclusive Phase 1 Clinical Trial of ‘Armored’ CAR T-Cell Therapy for Ovarian Cancer

Roswell Park Comprehensive Cancer Center is currently recruiting for a phase 1 clinical trial of the new therapy (NCT07489287), called GB-5267, which was co-developed by Roswell Park and the therapeutics company Generate:Biomedicines.

• June 24, 2026

• 3 min